US5837313A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Drug release stent coating process
Assignee: Boston Scientific Scimed Inc
•
Filing: 1996-06-13
•
Granted: 1998-11-17
•
Expires: 2016-06-13
Abstract
Abstract A method of coating implantable open lattice metallic stent prosthesis is disclosed which includes sequentially applying a plurality of relatively thin outer layers of a coating composition comprising a solvent mixture of uncured polymeric silicone material and crosslinker and finely divided biologically active species, possibly of controlled average particle size, to form a coating on each stent surface. The coatings are cured in situ and the coated, cured prosthesis are sterilized in a step that includes preferred pretreatment with argon gas plasma and exposure to gamma radiation electron beam, ethylene oxide, steam.
Inventors
- 👤 Ni Ding
- 👤 Michael N. Helmus
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 21:02
CPC Classifications
A; A61; A61L; A61L31/00; A61L31/14; A61L31/16; A61F; A61F2/00; A61F2/82; A61F2/86; A61F2/90; A61L27/00; A61L27/14; A61L27/22; A61L27/227; A61L31/08; A61L31/10; A61L31/141; A61L33/00; A61L33/0005; A61L33/0011; A61F2210/00; A61F2210/0014; A61F2250/00; A61F2250/0058; A61F2250/0067; A61L2300/00; A61L2300/20; A61L2300/22; A61L2300/222; A61L2300/23; A61L2300/236; A61L2300/40; A61L2300/404; A61L2300/406; A61L2300/42; A61L2300/60; A61L2300/602; A61L2300/606; A61L2300/608; A61L2300/62; A61L2300/622; A61L2420/00; A61L2420/02
Claims Analysis
Total Claims: 20
Claim 1
Independent Claim
131 words
A method of coating at least a portion of an implantable prosthesis, having at least one opening therein, with a hydrophobic elastomeric material incorporating an amount of biologically active material therein for timed delivery therefrom comprising the steps of: (a) applying a coating comprising the elastomeric material, a solvent and an amount of finely divided biologically active material onto at least a portion of the prosthesis; wherein when the biologically active material is particulate the average particle size of the biologically active material is less than or equal to about 15 μm; and wherein the coating is applied to the prosthesis in a manner to adheringly conform thereto to preserve the opening; and (b) curing the coating such that at least some of the biologically active material is particulate after curing.
Claim 2
Independent Claim
131 words
A method of coating at least a portion of an implantable prosthesis, having at least one opening therein, with a hydrophobic elastomeric material incorporating an amount of biologically active material therein for timed delivery therefrom comprising the steps of: (a) applying a coating comprising the elastomeric material, a solvent and an amount of finely divided biologically active material onto at least a portion of the prosthesis; wherein when the biologically active material is particulate the average particle size of the biologically active material is less than or equal to about 15 μm; and wherein the coating is applied to the prosthesis in a manner to adheringly conform thereto to preserve the opening; and (b) curing the coating such that at least some of the biologically active material is particulate after curing.
Claim 3
Dependent Claim
32 words
The method of claim 1 wherein the elastomeric material is selected from the group consisting of silicones, polyurethanes, polyamide elastomers, ethylene vinyl acetate copolymers, polyolefin elastomers, ethylene-propylene terpolymer rubbers and combinations thereof.
Claim 4
Dependent Claim
12 words
The method of claim 1 wherein the biologically active material includes heparin.
Claim 5
Dependent Claim
16 words
The method of claim 1 wherein the coating comprises about 25-45 weight percent biologically active material.
Claim 6
Dependent Claim
25 words
The method of claim 1 wherein the biologically active material has an average particle size less than or equal to about 10 μm before curing.
Claim 7
Dependent Claim
12 words
The method of claim 5 wherein the biologically active material includes heparin.
Claim 8
Independent Claim
102 words
A method of controlling the delivery of an eluting material incorporated in an elastomeric coating having at least one layer on at least a portion of an implantable prosthesis having at least one opening therein, the method comprising incorporating a biologically active particulate material having an average particle size of less than or equal to about 15 μm into at least one layer of the coating and applying the elastomeric coating in a manner which adheringly conforms to the surface to preserve the opening; and curing the coating such that at least some of the biologically active material is particulate after curing.
Claim 9
Independent Claim
102 words
A method of controlling the delivery of an eluting material incorporated in an elastomeric coating having at least one layer on at least a portion of an implantable prosthesis having at least one opening therein, the method comprising incorporating a biologically active particulate material having an average particle size of less than or equal to about 15 μm into at least one layer of the coating and applying the elastomeric coating in a manner which adheringly conforms to the surface to preserve the opening; and curing the coating such that at least some of the biologically active material is particulate after curing.
Claim 10
Dependent Claim
12 words
The method of claim 7 wherein said biologically active material is heparin.
Claim 11
Dependent Claim
16 words
The method of claim 7 wherein the layer comprises about 25-45 weight percent biologically active material.
Claim 12
Dependent Claim
21 words
The method of claim 7 wherein the biologically active material is incorporated to produce a substantially smooth surface on the prosthesis.
Claim 13
Dependent Claim
20 words
The method of claim 1 wherein the elastomeric material, solvent and biologically active material are applied by spraycoating the prosthesis.
Claim 14
Dependent Claim
20 words
The method of claim 1 wherein the elastomeric material, solvent and biologically active material are applied by dipping the prosthesis.
Claim 15
Dependent Claim
25 words
The method of claim 7 wherein the biologically active material has an average particle size less than or equal to about 10 μm before curing.
Claim 16
Dependent Claim
67 words
The method of claim 1 wherein the implantable prosthesis is an expandable stent having a tubular metal body having open ends and a sidewall structure having openings therein, and wherein the elastomeric material, solvent and biologically active material form a coating on a surface of said sidewall structure which continuously conforms to said sidewall structure in a manner that preserves the openings when the stent is expanded.
Claim 17
Dependent Claim
21 words
The method of claim 13 wherein the elastomeric material, solvent and biologically active material are applied with the stent fully expanded.
Claim 18
Dependent Claim
18 words
The method of claim 1 wherein the elastomeric material, solvent and biologically active material are in a mixture.
Claim 19
Dependent Claim
26 words
The method of claim 1 wherein the biologically active material has an average particle size of less than or equal to about 15 μm after curing.
Claim 20
Dependent Claim
26 words
The method of claim 5 wherein the biologically active material has an average particle size of less than or equal to about 15 μm after curing.
References Cited (Backward Citations)
US3932627A
Cited
US4613665A
Cited
US4655771B1
Cited
US4954126A
Cited
US4954126B1
Cited
US4655771A
Cited
US5061275A
Cited
US4886062A
Cited
US4916193A
Cited
US5185408A
Cited
US5182317A
Cited
US5338770A
Cited
US5262451A
Cited
US5226913A
Cited
US5092877A
Cited
US5308889A
Cited
US5292802A
Cited
US4994071A
Cited
US5415619A
Cited
WO1991012779A1
Cited
US5447724A
Cited
US5258020A
Cited
US5163952A
Cited
US5180366A
Cited
US5304121A
Cited
WO1992015286A1
Cited
US5356433A
Cited
US5429618A
Cited
US5578075B1
Cited
US5449382A
Cited
US5578075A
Cited
US5342348A
Cited
US5419760A
Cited
WO1994021308A1
Cited
WO1994021309A1
Cited
US5464650A
Cited
US5624411A
Cited
EP0623354A1
Cited
EP0734721A2
Cited
US5605696A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 2001-11-16 | 2002-05-18 | 2002-11-17 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2005-11-16 | 2006-05-18 | 2006-11-17 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2009-11-16 | 2010-05-18 | 2010-11-17 | $7700.00 | Window Closed / Lapsed |